MRVI - Maravai Lifesciences Holdings  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MRVI is currently covered by 6 analysts with an average price target of $5.78. This is a potential upside of $2.72 (88.89%) from yesterday's end of day stock price of $3.06.

Maravai Lifesciences Holdings 's activity chart (see below) currently has 129 price targets and 81 ratings on display. The stock rating distribution of MRVI is 71.43% BUY and 28.57% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 57.01% with an average time for these price targets to be met of 74.75 days.

Highest price target for MRVI is $8, Lowest price target is $2.5, average price target is $4.8.

Most recent stock forecast was given by BRANDON COUILLARD from WELLS FARGO on 15-Dec-2025. First documented stock forecast 15-Dec-2020.

Currently out of the existing stock ratings of MRVI, 5 are a BUY (71.43%), 2 are a HOLD (28.57%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 15-Dec-2020

$4.5

$1.4 (45.16%)

$21

2 months 9 days ago
(15-Dec-2025)

1/3 (33.33%)

$0.83 (22.62%)

48

Buy Since 15-Dec-2020

$4

$0.9 (29.03%)

3 months 17 days ago
(07-Nov-2025)

5/9 (55.56%)

$1.13 (39.37%)

105

$5

$1.9 (61.29%)

$10

10 months 30 days ago
(25-Mar-2025)

3/13 (23.08%)

$2.7 (117.39%)

133

Hold Since 10-Apr-2023

$2.5

$-0.6 (-19.35%)

$6

11 months 3 days ago
(21-Mar-2025)

4/7 (57.14%)

$0.23 (10.13%)

58

Buy Since 03-Nov-2022

$8

$4.9 (158.06%)

$9

11 months 21 days ago
(03-Mar-2025)

2/4 (50%)

$4.98 (164.90%)

112

Show more analysts

Please expand the browser size to see the chart

What is MRVI (Maravai Lifesciences Holdings ) average time for price targets to be met?

On average it took 74.75 days on average for the stock forecasts to be realized with a an average price target met ratio 57.01

Which analyst has the current highest performing score on MRVI (Maravai Lifesciences Holdings ) with a proven track record?

TEJAS SAVANT

Which analyst has the most public recommendations on MRVI (Maravai Lifesciences Holdings )?

Tejas Savant works at MORGAN STANLEY and has 25 price targets and 14 ratings on MRVI

Which analyst is the currently most bullish on MRVI (Maravai Lifesciences Holdings )?

Katie Tryhane with highest potential upside - $50.9

Which analyst is the currently most reserved on MRVI (Maravai Lifesciences Holdings )?

John Sourbeer with lowest potential downside - -$0.6

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?